Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)-Reference-Cited by-同舟云学术

Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)

Published:2017-06-20 Issue:7 Volume:6 Page:1541-1551
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Sabol Rachel A.¹,Noxon Virginia²,Sartor Oliver¹,Berger Joseph R.³,Qureshi Zaina⁴,Raisch Dennis W.⁵,Norris LeAnn B.²,Yarnold Paul R.²,Georgantopoulos Peter²,Hrushesky William J.²,Bobolts Laura⁶,Ray Paul²,Lebby Akida²,Kane Robert C.²,Bennett Charles L.²⁷⁸^ORCID

Affiliation:

1. Tulane University School of Medicine; New Orleans Louisiana

2. The Southern Network on Adverse Reactions (SONAR) program; University of South Carolina College of Pharmacy; Columbia South Carolina

3. Department of Neurology; Perelman School of Medicine; Philadelphia Pennsylvania

4. The Arnold School of Public Health; University of South Carolina; Columbia South Carolina

5. University of New Mexico; College of Pharmacy; Albuquerque New Mexico

6. Oncology Analytics; Plantation Florida

7. The Medical University of South Carolina Hollings Cancer Center; Charleston South Carolina

8. William Jennings Bryan Dorn Veterans Administration Medical Center; Columbia South Carolina

Funder

National Cancer Institute

Doris Levkoff Meddin grant

American Cancer Society

South Carolina SmartState Program

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference49 articles.

1. Natalizumab (Tysabri);Selewski;AJNR Am. J. Neuroradiol.,2010

2. Melanoma in multiple sclerosis treated with natalizumab: causal association or coincidence?;Bergamaschi;Mult. Scler.,2009

3. Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients;Nali;Arq. Neuropsiquiatr.,2014

4. Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions;Stüve;Arch. Neurol.,2007

5. Natalizumab therapy for multiple sclerosis;Derfuss;Semin. Neurol.,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple Sclerosis;Journal of Clinical Medicine;2024-08-29

2. Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society;Multiple Sclerosis Journal;2024-02-15

3. Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis;Frontiers in Cell and Developmental Biology;2023-04-26

4. Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors;Journal of the American Academy of Dermatology;2023-03

5. Multiple sclerosis and melanoma;Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova;2023